文献速递复苏、休克与脓毒症消化、代谢与肾脏急症

急诊医学临床药师执业者驱动的脓毒症抗菌药物干预的影响

Impact of emergency medicine clinical pharmacist practitioner-driven sepsis antibiotic interventions.
PubMed 文献 · Am J Emerg Med · 2023-11-11
一句话结论急诊医学临床药师执业者通过脓毒症会诊驱动方案,使脓毒症患者经验性抗菌药物选择合适率从57.5%升至86%,首剂给药时间缩短64分钟。

本研究为回顾性比较,纳入144例在急诊科开具抗菌药物的脓毒症患者,80例无药师干预,64例由急诊医学临床药师执业者经脓毒症药学会诊开药;药师查阅既往入院、培养及过敏史以指导疑似感染源用药并记录于电子病历。主要终点经验性抗菌药物合适率从57.5%(46/80)提高至86%(55/64)(差异28.5%;p<0.01),首剂给药时间缩短64分钟(p<0.01)。入院时升级抗菌药物、住院时间及院内死亡率组间无显著差异。作者认为该方案改善合适率与给药时间。

要点

  • 急诊医学临床药师执业者驱动的脓毒症会诊方案使经验性抗菌药物合适率从57.5%(46/80)升至86%(55/64)(差异28.5%;p<0.01)。
  • 药师干预组首剂抗菌药物给药时间缩短64分钟(p<0.01)。
  • 60分钟内给药比例、入院时升级抗菌药物、住院时间及院内死亡率组间无显著差异。
  • 药师查阅既往入院、培养及过敏史以指导疑似感染源选药,并按执业范围开嘱、于电子病历正式记录。
  • 2021年拯救脓毒症运动指南推荐脓毒症识别后第一小时内给予抗菌药物。

适用人群与场景

  • 在急诊科开具抗菌药物的脓毒症患者,比较无药师干预与急诊医学临床药师执业者经脓毒症会诊开药者。

处置流程与药物剂量

  • 急诊医学临床药师执业者查阅患者既往入院、培养数据及过敏史,以指导疑似感染源的抗菌药物选择,并在其执业范围内开嘱、于电子病历中正式记录。
  • 2021年拯救脓毒症运动指南推荐脓毒症识别后第一小时内给予抗菌药物。

研究设计与关键结果

  • 回顾性比较研究,共纳入144例患者:80例抗菌药物无药师干预,64例由急诊医学临床药师执业者开嘱。
  • 主要终点急诊科经验性抗菌药物选择合适率从57.5%(46/80)提高至86%(55/64)(差异28.5%;p<0.01)。
  • 首剂抗菌药物给药时间缩短64分钟(p<0.01)。
  • 60分钟内给予抗菌药物、入院时升级抗菌药物、住院时间及院内死亡率组间无显著差异。
  • 快速急诊医学评分(REMS)与院内死亡率的相关性为次要终点。

证据类型、等级与局限

  • 证据类型:回顾性比较研究。
  • 局限:原文报告为小型、单中心研究。

对床旁实践的改变

  • 作者认为,急诊医学临床药师执业者驱动的脓毒症方案可改善经验性抗菌药物选择合适率并缩短给药时间。

指南或共识出处

  • 2021年拯救脓毒症运动指南

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The 2021 Surviving Sepsis Campaign Guidelines recommend administration of antimicrobials within the first hour of recognition of sepsis. Over the last decade, several studies have demonstrated improved time-to-antibiotic administration and antibiotic appropriateness when a pharmacist was involved in the care of patients with sepsis. To our knowledge, no studies evaluating the appropriate use of antibiotics in sepsis driven entirely by an Emergency Medicine (EM) Clinical Pharmacist Practitioner (CPP) have been published. The purpose of this study is to evaluate the impact of an EM CPP-driven protocol on antimicrobial interventions in patients with sepsis in the emergency department (ED).

METHODS: This was a retrospective comparison of patients with sepsis for whom antimicrobials were ordered in the ED without pharmacist intervention to patients whose antimicrobials were ordered by an EM CPP via a sepsis consult to pharmacy. An EM CPP reviewed individual patient profiles for pertinent historical admissions, culture data, and allergy profiles to guide antimicrobial selection for the suspected source of infection and entered orders under their scope of practice with formal documentation in the electronic medical record (EMR). The primary objective of this study was to compare the rates of appropriate empiric antibiotic utilization in septic patients admitted from the ED pre- and post-protocol implementation. Secondary endpoints included the following, broadening of ED-initiated empiric antibiotics on hospital admission, time-to-antibiotic administration, in-hospital mortality, Rapid Emergency Medicine Score (REMS) association with in-hospital mortality, and hospital length of stay.

RESULTS: A total of 144 patients were included: 80 patients prescribed antibiotics without pharmacist intervention and 64 prescribed antibiotics by an EM CPP. Appropriate empiric antibiotic selection in the ED improved from 57.5% (46/80) to 86% (55/64) with EM CPP intervention (difference 28.5%; p < 0.01). Time-to-first antibiotic administration decreased by 64 min (p < 0.01). Administration of antibiotics within 60 min, broadening of antibiotics on admission, hospital length of stay, and in-hospital mortality did not significantly differ across groups.

CONCLUSIONS: In this small, single-center study, an EM Clinical Pharmacist Practitioner-driven protocol for patients with sepsis in the emergency department improved the rate of appropriate empiric antimicrobial selection and time-to-antibiotic administration.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Hammond A, Porter R, Lynch KE, et al. Impact of emergency medicine clinical pharmacist practitioner-driven sepsis antibiotic interventions. Am J Emerg Med. 2023. PMID: 37979228. doi:10.1016/j.ajem.2023.11.012

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。